Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bone marrow necrosis and degeneration.

M J Norgard, J T Carpenter, M E Conrad

    Archives of Internal Medicine
    |August 1, 1979
    PubMed
    Summary
    This summary is machine-generated.

    Bone marrow necrosis is often overlooked and appears common in various disorders, not just severe diseases. Further research is needed to understand its clinical significance.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    What is expert nursing care? a nursing director's viewpoint.

    The American journal of nursing·2010
    Same author

    Krukenberg tumors.

    Delaware state medical journal·2010
    Same author

    Iron absorption: relative importance of iron transport pathways.

    American journal of hematology·2001
    Same author

    Separate pathways for cellular uptake of ferric and ferrous iron.

    American journal of physiology. Gastrointestinal and liver physiology·2000
    Same author

    Abnormalities of flavin monooxygenase as an etiology for sideroblastic anemia.

    American journal of hematology·2000
    Same author

    Iron absorption and transport-an update.

    American journal of hematology·2000

    Area of Science:

    • Pathology
    • Hematology

    Background:

    • Bone marrow necrosis is typically considered a rare finding in living patients.
    • It has been associated with poor prognosis in hematologic diseases and metastatic carcinoma.